Consensi is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Burke Therapeutics, Llc. The primary component is Amlodipine Besylate; Celecoxib.
Product ID | 69101-502_99e8566d-75ed-391f-e053-2995a90af8f2 |
NDC | 69101-502 |
Product Type | Human Prescription Drug |
Proprietary Name | Consensi |
Generic Name | Amlodipine Besylate And Celecoxib |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-12-17 |
Marketing Category | NDA / NDA |
Application Number | NDA210045 |
Labeler Name | Burke Therapeutics, LLC |
Substance Name | AMLODIPINE BESYLATE; CELECOXIB |
Active Ingredient Strength | 3 mg/1; mg/1 |
Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-12-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA210045 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-12-17 |
Marketing Category | NDA |
Application Number | NDA210045 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-12-17 |
Ingredient | Strength |
---|---|
AMLODIPINE BESYLATE | 2.5 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
69101-502 | Consensi | amlodipine besylate and celecoxib |
69101-505 | Consensi | amlodipine besylate and celecoxib |
69101-510 | Consensi | amlodipine besylate and celecoxib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CONSENSI 87295108 not registered Live/Pending |
Kitov Pharmaceuticals Ltd. 2017-01-10 |